Search Within

Marc Ladanyi

Formats
  1. Journal Article (653)
  2. Meeting Abstract (644)
  3. Book Section (13)
  4. Research Letter (8)
  5. Review (7)
  6. Editorial (5)
  7. Guidelines (3)
  8. Conference Paper (1)
  9. Correspondence (1)
  10. Miscellaneous (1)
Groups
  1. Department of Pathology and Laboratory Medicine (1336)
  2. GSK Faculty (1336)
  3. Human Oncology and Pathogenesis Program (1336)
  4. Tow Center for Developmental Oncology (TCDO) (1336)
  5. Department of Medicine (647)
  6. Solid Tumor Oncology Division (618)

More Groups

People
  1. Maria Arcila (303)
  2. Michael Berger (220)
  3. Mark Kris (191)
  4. Gregory Riely (188)
  5. Ahmet Zehir (178)
  6. Natasha Rekhtman (134)

More People

Years
  1. 2025 (23)
  2. 2024 (37)
  3. 2023 (48)
  4. 2022 (72)
  5. 2021 (62)
  6. 2020 (63)

More Years

Publications
  1. Modern Pathology (189)
  2. Laboratory Investigation (155)
  3. Journal of Clinical Oncology (127)
  4. Journal of Molecular Diagnostics (94)
  5. Clinical Cancer Research (87)
  6. Journal of Thoracic Oncology (77)

More Publications

Publishers
  1. Nature Publishing Group (225)
  2. American Association for Cancer Research (202)
  3. Nature Research (191)
  4. American Society of Clinical Oncology (152)
  5. Elsevier Science, Inc. (121)
  6. Elsevier Inc. (97)

More Publishers

Results (1336)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Clinicopathologic characteristics of NRG1 fusion-positive cancers: A single-institution study
    Meeting Abstract

    Schram, A. M.; Benayed, R.; Somwar, R.; Rekhtman, N.; Arcila, M. E.; Ladanyi, M.; Hyman, D. M.; Drilon, A. E.
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Tissue-based molecular and histological landscape of acquired resistance to osimertinib given initially or at relapse in patients with EGFR-mutant lung cancers
    Meeting Abstract

    Schoenfeld, A. J.; Chan, J. M.; Rizvi, H.; Rekhtman, N.; Daneshbod, Y.; Kubota, D.; Chang, J. C.; Arcila, M. E.; Ladanyi, M.; Somwar, R.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Molecular correlates of PD-L1 expression in patients with non-small cell lung cancer
    Meeting Abstract

    Rizvi, H.; Bandlamudi, C.; Schoenfeld, A. J.; Sauter, J. L.; Arbour, K. C.; Beras, A.; Egger, J. V.; Ladanyi, M.; Donoghue, M.; Rudin, C. M.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Influence of WNT and DNA damage response pathway alterations on outcomes in patients with unresectable metastatic colorectal cancer
    Meeting Abstract

    Mondaca, S.; Walch, H. S.; Nandakumar, S.; Chatila, W. K.; Hechtman, J. F.; Cercek, A.; Diaz, L. A.; Sanchez-Vega, F.; Kemeny, N. E.; Segal, N. H.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Tumor volumetric correlation with plasma cell free DNA (cfDNA) mutation detection in metastatic lung cancers
    Meeting Abstract

    Haseltine, J.; Offin, M.; Myers, M. L.; Makhnin, A.; Adamski, A.; Li, H.; Li, M.; Shaffer, T.; Henderson, S.; Shen, R.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • MET inhibitor resistance in patients with MET exon 14-altered lung cancers
    Meeting Abstract

    Guo, R.; Offin, M.; Brannon, A. R.; Chow, A.; Delasos, L.; Somwar, R.; Wilkins, O.; Scott, K.; Tian, Y.; Cecchi, F.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Clinical validation of a genomics-based classifier to predict tissue of origin from targeted tumor sequencing
    Meeting Abstract

    Zheng, Y.; Penson, A. V.; Camacho, N.; Biederstedt, E.; Zehir, A.; Kandoth, C.; Syed, A.; Varghese, A. M.; Al-Ahmadie, H. A.; Schultz, N.; more...
    Cancer Research (2019)

    Fulltext@MSK | Save
  • Prospective clinical sequencing distinguishes independent primary cancers from recurrent or metastatic disease
    Meeting Abstract

    Schram, A. M.; Bandlamudi, C.; Zehir, A.; Ladanyi, M.; Berger, M. F.; Taylor, B. S.; Hyman, D. M.
    Cancer Research (2019)

    Fulltext@MSK | Save
  • Inherited truncating RAD52 variant discovered using integrated germline-somatic analysis predicts clinical outcome in patients with lung cancers
    Meeting Abstract

    Mukherjee, S.; Srinivasan, P.; Bandlamudi, C.; Hellmann, M. D.; Ravichandran, V.; Selvan, M. E.; Kemel, Y.; Mandelker, D.; Zauderer, M.; Walsh, M.; more...
    Cancer Research (2019)

    Fulltext@MSK | Save
  • BRCA-mediated tumorigenesis is origin and cell-type dependent
    Meeting Abstract

    Jonsson, P.; Cheng, M. L.; Bandlamudi, C.; Srinivasan, P.; Chavan, S. S.; Friedman, N. D.; Rosen, E. Y.; Richards, A. L.; Bouvier, N.; Selcuklu, S. D.; more...
    Cancer Research (2019)

    Fulltext@MSK | Save